Management Team

The executive team of Madeira Therapeutics has over 125 years of combined experience to its credit and has launched more than 50 FDA-approved drugs.


Peter R. Joiner
CEO, Madeira Therapeutics

 

Joiner has a 30-year history in sales, sales management and marketing for pharmaceutical companies.  He has launched over 15 major pharmaceutical products and was previously a part of the senior management team at Alliant Pharmaceuticals.

 

Kenneth V. Phelps
Chief Scientific Officer, Madeira Therapeutics
President & CEO, Camargo Pharmaceutical Services, LLC

 

Phelps is an industry expert in 505(b)(2) FDA submissions. He has aided in the successful FDA approval of numerous compounds. Today Phelps is the President & CEO of Camargo Pharmaceutical Services based in Cincinnati, Ohio. Prior to founding Camargo, he held a number of executive level assignments in the areas of quality control, project management and regulatory, clinical and medical affairs at Duramed Pharmaceuticals (now Barr Pharmaceuticals).